FinanceAYR Wellness Has No Estimate for Q1 2025 Interim Filings; Trading Remains on HoldThe cannabis company’s delay in filing its financial statements comes as its negotiations with creditors remain ongoing.AYR Wellness Inc.Posted by CBT StaffJune 27, 2025Recommended4Front Ventures’ Receivership Proceedings Progress; Board Members ResignAurora Cannabis Denies 2nd ‘False’ News Report of Acquisition of MedLeaf TherapeuticsVireo Growth Provides Corporate Update After Closing All Merger TransactionsAYR Fails to Complete Q1 2025 Interim Financial Filings; Cease-Trade Order Remains in EffectRelated StoriesAurora Cannabis Denies 2nd ‘False’ News Report of Acquisition of MedLeaf TherapeuticsVireo Growth Provides Corporate Update After Closing All Merger TransactionsAYR Fails to Complete Q1 2025 Interim Financial Filings; Cease-Trade Order Remains in EffectAYR Wellness Issued Cease Trade Order by Ontario Securities Commission